We continue to expand our in silico technology and this month released DDI-Fusion which predicts human drug-drug interactions from structural information and in vitro data. The new addition complements our existing chemPK™, chemTox and chemTarget products as early prediction tools.
We had a strong presence at ELRIG in Liverpool on 13-14 October 2016. Our Head of Toxicology, Dr Paul Walker, and Senior Research Scientist, Dr Stephanie Ryder, were speakers at the event and gave presentations on our latest 3D research at Cyprotex. In October, we also presented posters at the DMDG meeting and ESTIV congress.Find out more about DDI-Fusion or download our research below